TSE:4974 - Takara Bio Inc Takara Bio Inc
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance
Balance Sheet Cash Flow Key Ratios Personalized

Graphs are exclusive for members only

Sign up for free to access most features of StocksCafe

Show %
2005 Q1 2006 Q1 2007 Q1 2008 Q1 2008 Q3 2008 Q4 2009 Q1 2009 Q2 2009 Q3 2009 Q4 2010 Q1 2010 Q2 2010 Q3 2010 Q4 2011 Q1 2011 Q2 2011 Q3 2011 Q4 2012 Q1 2012 Q2 2012 Q3 2012 Q4 2013 Q1 2013 Q2 2013 Q3 2013 Q4 2014 Q1 2014 Q2 2014 Q3 2014 Q4 2015 Q1 2015 Q2 2015 Q3 2015 Q4 2016 Q1 2016 Q2 2016 Q3 2016 Q4 2017 Q1 2017 Q2 2017 Q3 2017 Q4 2018 Q1 2018 Q2 2018 Q3 2018 Q4 2019 Q1 2019 Q2 2019 Q3 2019 Q4 2020 Q1 2020 Q2 2020 Q3 2020 Q4 2021 Q1 2021 Q2 Graph
Total Revenue [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 35.55B
0.0%
35.84B
0.8%
35.64B
-0.5%
34.92B
-2.0%
34.51B
-1.2%
34.56B
0.2%
32.85B
-5.0%
35.51B
8.1%
39.56B
11.4%
46.09B
16.5%
54.42B
18.1%
Cost of Revenue [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 14.72B
-0.1%
15.15B
2.9%
14.4B
-5.0%
14.23B
-1.2%
13.97B
-1.8%
13.46B
-3.7%
12.96B
-3.7%
12.9B
-0.4%
11.99B
-7.1%
14.21B
18.6%
14.11B
-0.7%
Gross Profit [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 20.83B
0.1%
20.68B
-0.7%
21.25B
2.7%
20.69B
-2.6%
20.54B
-0.8%
21.11B
2.8%
19.89B
-5.7%
22.6B
13.6%
27.57B
22.0%
31.87B
15.6%
40.31B
26.5%
Total Expenses [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 30.17B
0.4%
30.37B
0.7%
29.47B
-3.0%
29.04B
-1.5%
28.6B
-1.5%
28.29B
-1.1%
28.13B
-0.6%
28.53B
1.4%
28.36B
-0.6%
32.13B
13.3%
32.65B
1.6%
Operating Expense [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 15.45B
0.8%
15.22B
-1.5%
15.07B
-1.0%
14.81B
-1.7%
14.62B
-1.3%
14.83B
1.4%
15.17B
2.3%
15.62B
3.0%
16.38B
4.8%
17.92B
9.4%
18.54B
3.5%
Operating Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 5.38B
-2.0%
5.47B
1.5%
6.17B
12.9%
5.88B
-4.8%
5.91B
0.6%
6.28B
6.2%
4.72B
-24.8%
6.98B
47.9%
11.19B
60.3%
13.96B
24.7%
21.77B
56.0%
Net Income (Cont Operations) [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 4.32B
-14.4%
4.82B
11.6%
5.47B
13.3%
5.34B
-2.4%
6B
12.5%
5.43B
-9.5%
3.98B
-26.8%
5.76B
44.9%
9.91B
71.9%
13.55B
36.8%
21.38B
57.7%
Net Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 3.35B
-10.6%
3.66B
9.0%
4.22B
15.3%
4.01B
-4.8%
4.28B
6.6%
3.82B
-10.7%
2.63B
-31.1%
4.02B
52.7%
6.84B
70.2%
9.55B
39.6%
15.17B
58.9%
Diluted Net Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 3.35B
-10.6%
3.66B
9.0%
4.22B
15.3%
4.01B
-4.8%
4.28B
6.6%
3.82B
-10.7%
2.63B
-31.1%
4.02B
52.7%
6.84B
70.2%
9.55B
39.6%
15.17B
58.9%
Basic EPS [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 27.86
-10.6%
30.38
9.0%
35.03
15.3%
33.32
-4.9%
35.52
6.6%
31.72
-10.7%
21.86
-31.1%
33.38
52.7%
56.79
70.1%
79.29
39.6%
125.97
58.9%
Diluted EPS [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 27.86
-10.6%
30.38
9.0%
35.03
15.3%
33.32
-4.9%
35.52
6.6%
31.72
-10.7%
21.86
-31.1%
33.38
52.7%
56.79
70.1%
79.29
39.6%
125.97
58.9%
Values are in JPY whenever applicable | Fiscal year ends on March 31
Powered by Morningstar